Donor B-type natriuretic peptide predicts early cardiac performance after heart transplantation-Reference-Cited by-同舟云学术

Donor B-type natriuretic peptide predicts early cardiac performance after heart transplantation

Published:2012-06 Issue:6 Volume:31 Page:579-584
ISSN:1053-2498
Container-title:The Journal of Heart and Lung Transplantation
language:en
Short-container-title:The Journal of Heart and Lung Transplantation

Author:

Vorlat Anne,Conraads Viviane M.,Jorens Philippe G.,Aerts Sophie,Van Gorp Sara,Vermeulen Tom,Van Herck Paul,Van Hoof Viviane O.,Rodrigus Inez,Vrints Christiaan J.M.,Claeys Marc J.

Publisher

Elsevier BV

Subject

Transplantation,Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference24 articles.

1. Marginal donor grafts in heart transplantation: lessons learned from 25 years of experience;Wittwer;Transpl Int,2008

2. Evaluation of donor cardiac function for heart transplantation: experience of a French academic hospital;Boudaa;Ann Transplant,2000

3. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes;de Lemos;N Engl J Med,2001

4. N-terminal pro-brain natriuretic peptide;Gardner;Eur Heart J,2003

5. The potential to improve primary prevention in the future by using BNP/N-BNP as an indicator of silent ‘pancardiac’ target organ damage: BNP/N-BNP could become for the heart what microalbuminuria is for the kidney;Struthers;Eur Heart J,2007

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Usefulness of biomarkers to predict prognosis after heart transplant;Revista Española de Cardiología (English Edition);2024-06

2. Utilidad de los biomarcadores en el trasplante cardiaco para predecir el pronóstico;Revista Española de Cardiología;2024-04

3. Donor heart selection: Evidence-based guidelines for providers;The Journal of Heart and Lung Transplantation;2023-01

4. Primary Graft Dysfunction after Heart Transplantation;Heart Transplantation - New Insights in Therapeutic Strategies;2022-07-13

5. Suppression of tumorigenicity‐2 (ST2) is a promising biomarker in heart transplantation;Clinical Transplantation;2022-02-22